Takara Ebitda from 2010 to 2026
| TF2 Stock | EUR 6.10 0.25 4.27% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 29.9 B | Current Value 18.2 B | Quarterly Volatility 9.7 B |
Check Takara Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takara Bio's main balance sheet or income statement drivers, such as Interest Expense of 24.1 M, Selling General Administrative of 601.1 M or Total Revenue of 45.1 B, as well as many indicators such as . Takara financial statements analysis is a perfect complement when working with Takara Bio Valuation or Volatility modules.
Takara | Ebitda |
The Ebitda trend for Takara Bio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Takara Bio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Takara Bio's Ebitda Growth Pattern
Below is the plot of the Ebitda of Takara Bio over the last few years. It is Takara Bio's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takara Bio's overall financial position and show how it may be relating to other accounts over time.
| Ebitda | 10 Years Trend |
|
Ebitda |
| Timeline |
Takara Ebitda Regression Statistics
| Arithmetic Mean | 14,453,965,686 | |
| Geometric Mean | 11,725,391,211 | |
| Coefficient Of Variation | 67.27 | |
| Mean Deviation | 8,700,194,925 | |
| Median | 8,842,000,000 | |
| Standard Deviation | 9,722,603,775 | |
| Sample Variance | 94529024.2T | |
| Range | 25.1B | |
| R-Value | 0.82 | |
| Mean Square Error | 32622249T | |
| R-Squared | 0.68 | |
| Significance | 0.000051 | |
| Slope | 1,583,563,440 | |
| Total Sum of Squares | 1512464386.6T |
Takara Ebitda History
About Takara Bio Financial Statements
Takara Bio stakeholders use historical fundamental indicators, such as Takara Bio's Ebitda, to determine how well the company is positioned to perform in the future. Although Takara Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Takara Bio's assets and liabilities are reflected in the revenues and expenses on Takara Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Takara Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBITDA | 29.9 B | 18.2 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Takara Stock
Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.